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Objectives: To determine optimum measurements for
abdominal obesity and to assess the prevalence and
determinants of metabolic syndrome in Qatar.
Design: National health survey.
Setting: Qatar National STEPwise Survey conducted
by the Supreme Council of Health during 2012.
Participants: 2496 Qatari citizens aged 18–64
representative of the general population.
Primary and secondary outcome measures:
Measure of obesity (body mass index, waist
circumference or waist-to-height ratio) that best
identified the presence of at least 2 other factors of
metabolic syndrome; cut-off values of waist
circumference; frequency of metabolic syndrome.
Results: Waist circumference ≥102 for men and
≥94 cm for women was the best predictor of the
presence of other determinants of metabolic syndrome
(raised blood pressure, fasting blood glucose,
triglycerides and reduced high-density lipoprotein
cholesterol). Using these values, we identified 28% of
Qataris with metabolic syndrome, which is
considerably lower than the estimate of 37% calculated
using the International Diabetes Federation (IDF)
criteria. Restricting the analysis to participants without
known elevated blood pressure, elevated blood sugar
or diabetes 16.5% would be classified as having
metabolic syndrome. In a multivariable logistic
regression analysis, the prevalence of metabolic
syndrome increased steadily with age (OR=3.40 (95%
CI 2.02 to 5.74), OR=5.66 (3.65 to 8.78), OR=10.2
(5.98 to 17.6) and OR=18.2 (7.01 to 47.5) for those in
the age group ‘30–39’, ‘40–49’, ‘50–59’, ‘60–64’ vs
‘18–29’; p<0.0001), decreased with increasing
educational attainment (OR=0.61 (0.39 to 0.96) for
those who attained ‘secondary school or more’
compared with ‘less than primary school’; p=0.03) and
exercise (OR=0.60 (0.42 to 0.86) for those exercising
≥3000 vs <600 MET-min/week; p=0.006) but was not
associated with smoking or diet.
Conclusions: Waist circumference was the best
measure of obesity to combine with other variables to
construct a country-specific definition of metabolic
syndrome in Qatar. Approximately 28% of adult Qatari
citizens satisfy the criteria for metabolic syndrome,
which increased significantly with age. Education and
physical activity were inversely associated with this
syndrome.
INTRODUCTION
Metabolic syndrome is a combination of indi-
vidual risk factors that are associated with
several serious health conditions such as dia-
betes, cardiovascular disease or stroke. It is dia-
gnosed by the presence of three or more of
five risk factors: abdominal obesity, raised
blood pressure (BP), raised fasting blood
glucose, raised triglycerides and reduced
high-density lipoprotein (HDL) cholesterol.
The prevalence of metabolic syndrome is
therefore highly dependent on the cut-off
points used for the definition of each single
component of metabolic syndrome, and par-
ticularly for the definition of abdominal
obesity. Abdominal obesity is normally mea-
sured by waist circumference and broad
ethnic-group suboptimal cut-off points have
been proposed.1 2 Until more specific data are
available for Middle East countries, the
International Diabetes Federation (IDF)
Strengths and limitations of this study
▪ This is the first study to establish optimal cut-off
values for waist circumference for Qataris, which
is a crucial criterion for a realistic estimation of
the prevalence of metabolic syndrome in this
population.
▪ The study is based on a WHO STEPS survey, a
well-established and tested method specifically
for chronic non-communicable diseases (NCD)
risk factor surveillance.
▪ As for any population survey, the assumption is
made that the sample of individuals interviewed
is representative of the whole population.
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recommended using European cut-off points for all Eastern
Mediterranean and Middle East (Arab) populations.1
The aims of this study were: first, to confirm results
from a previous study3 showing that waist circumference
was an appropriate measure of central obesity for the
identification of metabolic syndrome among Qatari citi-
zens; second, to assess optimal cut-off points for waist cir-
cumference in Qataris from data in a representative
National Health Survey; third, to use these cut-off points
to determine the prevalence and fourth, the determi-
nants of metabolic syndrome among Qatari citizens.
MATERIALS AND METHODS
Survey instrument and sampling
Qatar had a total adult population of about 1.5 million
inhabitants in 2010 comprising 240 000 Qatari Nationals
(39% aged <15, 58% aged 15–64 and 3% aged 65 or
more).4
We obtained survey data from a random sample of
2496 adult Qatari citizens aged 18–64 that were collected
during the year 2012 by the trained Qatar Supreme
Council of Health staff based on the WHO’s established
method for estimating non-communicable diseases
prevalence and risk factors, as part of surveillance.
The same standardised questions and protocols have
been used in many WHO member countries for moni-
toring within-country trends and for making compari-
sons across countries. General details on the survey are
available at the WHO website,5 and country-specific
details are available in a report from the Supreme
Council of Health, Qatar.6 Briefly, a two-stage sample
design was used, selecting primary sampling units
(PSUs) at the first stage and a sample of households
within each selected PSU at the second stage. A total of
96 PSUs were selected from the Qatari frame of PSUs.
In the second stage, 30 households were selected from
each selected PSU by simple systematic sampling.
Interviewers visited each selected household and identi-
fied all survey-eligible individuals. A personal digital
assistant device was used to generate a random number
to select one individual, either male or female, from
within the household. Only these selected individuals
were administered the questionnaire at their household.
Since biomedical tests require 12 hours of fasting,
appointments were given based on the agreement
between the interviewers and the respondents and were
conducted at the household level on Saturdays. In total
2496 of the 2850 Qatari households selected were inter-
viewed, corresponding to an overall response rate of
88%. An Arabic standardised version of the stepwise
data collection form (Questionnaire) was used in the
survey, gathering:
▸ Demographic and behavioural risk factors: age, sex,
years at school, tobacco and smokeless tobacco use,
types of physical activity, sedentary behaviour, fruit
and vegetable consumption, history of raised BP,
history of diabetes and oral health;
▸ Physical measurements: height and weight, waist cir-
cumference, hip circumference, BP;
▸ Blood samples for biochemical measurements: fasting
blood glucose, total cholesterol, HDL cholesterol,
LDL-cholesterol and triglycerides.
All the Qatar national STEPwise questionnaires were
tested for cultural applicability and sensitivity through
word and pilot testing of the questionnaires.
This research proposal had been previously reviewed
and approved by the Qatar Supreme Council of Health.
The Office of Research Integrity at Weill Cornell
Medical College in Qatar reviewed the proposal for sec-
ondary research analysis of those data by the authors
and determined that such secondary analysis was
exempt from Qatari and American human subject pro-
tection regulations and therefore did not require review
by an institutional review board.
Definition of metabolic syndrome and physical activity
assessment
Metabolic syndrome was defined according to the IDF
criteria.1 It combines several individual risk factors
including raised fasting blood glucose (≥100 mg/dL
or taking diabetes medication), raised BP (systolic
BP≥130 mm Hg or diastolic BP≥85 mm Hg, or tak-
ing anti-hypertensive medication), raised triglycerides
(≥150 mg/dL), reduced HDL cholesterol (<40 in men
or <50 mg/dL in women) and central obesity defined as
waist circumference with ethnicity specific values (using
Qatar-specific cut-offs estimated from this study: waist cir-
cumference ≥102 in men or ≥94 cm in women or body
mass index (BMI)≥30 kg/m2). According to the IDF cri-
teria,1 if BMI is >30 kg/m2, central obesity can be
assumed and waist circumference does not need to be
measured. If three or more of these risk factors are
present, then metabolic syndrome is present.1
We calculated the total physical activity using the
Global Physical Activity Questionnaire developed by the
WHO.7 This instrument collects information on physical
activity participation in three settings (activity at work,
travel to and from places, recreational activities) and sed-
entary behaviour. Participants were categorised into low,
moderate and high levels of activity based on the sum of
their total metabolic equivalent (MET)-minutes of activ-
ity computed for each setting (1 MET being defined as
1 kcal/kg/hour and is equivalent to the energy cost of
sitting quietly).
Data analysis
Demographic and health characteristics of the Qatari
population were evaluated using data from a cross-
sectional WHO STEPwise survey conducted in 2012.
The STEPS tool was designed to cover three levels of
risk factor assessment: step 1—demographic and behav-
ioural risk factors information, step 2—physical measure-
ments in household settings and step 3—biochemical
measurements. The data were weighted using popula-
tion weights to adjust for age and sex differences
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between the sample and the national population.
Percentages, means and corresponding 95% CIs were
then calculated using the weighted data. Comparison of
percentages across groups of participants was assessed
using the Rao-Scott χ2 test, which is a design-adjusted
version of the Pearson χ2 test.
We evaluated the prevalence of each single compo-
nent of metabolic syndrome in men and women by dif-
ferent age groups. We used the receiver operator
characteristic (ROC) curve analysis to assess the per-
formance of various measures of obesity (BMI, waist cir-
cumference, waist-to-height ratio) for the identification
of those with at least two other components of metabolic
syndrome and calculated the area under the curve
(AUC) (or ‘c-statistic’) to assess the prediction ability of
each parameter. Optimal waist circumference cut-off
points that maximise total accuracy (sensitivity and speci-
ficity) were calculated by the intersection of the plots of
sensitivity and specificity separately for men and for
women and combined with other measurements to
assess the prevalence of metabolic syndrome in Qatar.
Finally, we searched for lifestyle factors associated with
metabolic syndrome using logistic regression, adjusting
models for potential confounders such as age, gender or
educational attainment level. When present, missing
data were treated as a separate category and represented
by dummy variables, allowing logistic regression models
to be fitted on the whole population.
Data analysis was performed using the SURVEYFREQ,
SURVEYMEANS, SURVEYREG and SURVEYLOGISTIC
procedures of the SAS software (V.9.2, Cary, North
Carolina, USA). All tests were two-sided and p values
<0.05 considered statistically significant.
RESULTS
The survey sample consisted of 1053 male and 1443
female Qataris. Table 1 contains sociodemographic
characteristics of participants according to gender.
Significant gender-related differences were observed for
educational attainment, with significantly more women
(14.6%) than men (5.4%) who had attained less than
primary school, for marital status with more women than
men being divorced or widowed (6.4% and 3.9%, respect-
ively, for women and 2.2% and 0.2% for men) and for
occupation with the majority of men (64.7%) being gov-
ernment employees, while homemakers were the largest
group in women (38.8%) (p<0.0001). The age distribu-
tion (p=0.21) was similar in men and women.
Best obesity measure that predicts metabolic syndrome
We performed ROC curve analysis to determine which
obesity measure (BMI, waist circumference or
waist-to-height ratio) and the corresponding cut-off
points that best predict metabolic syndrome. For this
analysis, we plotted the sensitivity versus 1-specificity for
all possible values of the three obesity measures to
predict the presence of at least two of the four remain-
ing factors of metabolic syndrome (raised BP, raised
fasting blood glucose, raised triglycerides or reduced
Table 1 Sociodemographic characteristics of participants according to gender




Age group (years) 0.21
18–29 40.1 39.6 40.6
30–39 25.7 27.5 24.0
40–49 19.5 17.8 21.1
50–59 11.1 11.0 11.2
60–64 3.6 4.1 3.1
Educational attainment <0.0001
Secondary school or more 67.0 67.4 66.7
Primary/preparatory school 22.8 27.1 18.7
Less than primary school 10.1 5.4 14.6
Marital status <0.0001
Never married 29.8 30.1 29.5
Currently married 63.8 67.5 60.2
Divorced 4.3 2.2 6.4
Widowed 2.1 0.2 3.9
Occupation <0.0001
Government employee 49.1 64.7 34.0
Non-government employee 5.6 8.7 2.7
Student 13.4 11.3 15.5
Homemaker 19.9 0.5 38.8
Retired 7.5 8.8 6.3
Other 4.4 6.1 2.7
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HDL cholesterol) (figure 1). Waist circumference and
waist-to-height ratio were better predictors of metabolic
syndrome than BMI in men and women, yielding
respective moderate AUC of 0.612, 0.620 and 0.579 in
men and 0.722, 0.728 and 0.685 in women. The classi-
fier performance of waist circumference is, however,
only poor in men and fair in women.
We therefore confirmed that waist circumference (cri-
teria used by the IDF), which has similar predictive
value of metabolic syndrome than waist-to-height ratio
and necessitates a single measurement with no calcula-
tion, is an appropriate measure of central obesity. The
waist circumference cut-off points that maximised total
accuracy (sensitivity and specificity) were 102 for men
and 94 cm for women, respectively. The corresponding
sensitivity and specificity for the detection of metabolic
syndrome were 57.8% and 58.4% in men and 65.7%
and 66.7% in women.
Waist circumference distribution
We assessed the waist circumference of Qatari men and
women and the proportion of those with measures
above cut-off points defined by the IDF in the absence
of ethnic-specific values (≥94 for men and ≥80 cm for
women), Adult Treatment Panel III (ATP-III) (≥102 for
men and ≥88 cm for women) or obtained from the pre-
vious ROC curves analysis for Qatari citizens (≥102 for
men and ≥94 cm for women) (table 2). Average waist
circumference was 100 cm (95% CI 98 to 102) for men
and 90 cm (95% CI 88 to 92) for women. Average waist
circumference increased steadily with age in both sexes
to reach 106 cm (95% CI 101 to 112) and 103 cm (95%
CI 98 to 108), respectively, for men and women aged
60–64. Using the cut-off points proposed by the IDF
(≥94 for men and ≥80 cm for women, ie, the same as
those used for Europeans), 63.4% of men and 68.5% of
women would be at risk, with the proportion as high as
77.1% in men and 92.4% in women aged 60 or more.
Using the less-stringent ATP-III2 cut-off points (≥102 for
men and ≥88 cm for women), the proportion of men
and women with a waist circumference indicative of
central obesity will diminish to 45.4% and 51.3%,
respectively (for all age groups). Using Qatar-specific
cut-off points identified by ROC curve analysis (≥102 for
men and ≥94 cm for women), only 45.4% of men and
38.7% of women would be considered to have waist
measurement indicative of central obesity.
Prevalence of metabolic syndrome
The prevalence of metabolic syndrome and its compo-
nents is presented in table 3, stratified by gender and
age group. This information was collected at different
steps of the survey and was available for a variable
number of participants (1470 for fasting blood glucose,
2342 for BP, 1518 for triglycerides level, 1526 for HDL
cholesterol and 2356 for abdominal obesity). As a result,
information on metabolic syndrome was available for
1373 (55%) participants.
Considering all age groups together, reduced HDL
cholesterol (51.9%) and abdominal obesity (50.7%)
were the most common single components of metabolic
syndrome in men, while abdominal obesity (50.5%) and
raised BP (43.3%) were the most common single com-
ponents of metabolic syndrome in women.
Overall, the prevalence of metabolic syndrome in
Qatar based on country-specific estimates of waist
Figure 1 Receiver operator characteristic (ROC) curves for body mass index, waist circumference and waist-to-height ratio to
predict the presence of at least two factors of metabolic syndrome (excluding abdominal obesity) in men and women in Qatar.
Information on body mass index was available for 2384 participants, waist circumference for 2335 participants and waist-to-height
ratio for 2333 participants.
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circumference was 27.7% (95% CI 24.5% to 30.9%) for
both sexes combined, 28.7% (95% CI 23.6% to 33.7%)
in men and 26.8% (95% CI 23.1% to 30.4%) in women.
This prevalence increases with age from 9.3% (95% CI
6.0% to 12.7%) in those under the age of 30 to 70.2%
(95% CI 54.1% to 86.3%) in those aged 60–64.
Determinants of metabolic syndrome
We used multivariable logistic regression to identify
sociodemographic or lifestyle factors associated with
metabolic syndrome (table 4). After adjustment for age
and educational attainment level, gender was not asso-
ciated with the risk of metabolic syndrome. The risk of
metabolic syndrome, however, significantly increased
with increasing age with OR=3.40 (95% CI 2.02 to 5.74);
OR=5.66 (95% CI 3.65 to 8.78); OR=10.2 (95% CI 5.98
to 17.6) and OR=18.2 (95% CI 7.01 to 47.5) for those in
the age group ‘30–39’, ‘40–49’, ‘50–59’, ‘60–64’ com-
pared with those in the ‘18–29’ age group (p<0.0001),
but decreased with increasing educational attainment
with OR=0.61 (95% CI 0.39 to 0.96) for those who
attained ‘secondary school or more’ compared with ‘less
than primary school’ (p=0.03). No statistical significant
association was observed for marital status or occupation.
The particularly low but not statistically significant risk
for students may be in part due to residual confounding
from age, marital status and physical activity.
Neither tobacco smoking nor any single component
of the diet recorded at the survey (see online supple-
mentary table) was associated with metabolic syndrome.
After adjustment for age, gender and educational attain-
ment, the risk of metabolic syndrome was reduced by
40% for those with high physical activity levels (at least
3000 MET-min/week) compared with those with low
physical activity level (<600 MET-min/week) (OR=0.60;
95% CI 0.42 to 0.86) (p=0.006).
Metabolic syndrome among ‘healthy’ individuals
The survey was conducted to be representative of the
general population and therefore included a proportion
of participants with previous diagnosis of diabetes or
hypertension. Overall, 70% of the participants with avail-
able information about metabolic syndrome had never
been previously told by a doctor or other health worker
that they had either hypertension or diabetes. We reas-
sessed the prevalence of metabolic syndrome and its
components among these presumed ‘healthy partici-
pants’ (table 5). In this subset, the survey eventually
found that 13.7% (95% CI 10.1% to 17.2%) had ele-
vated fasting blood glucose, and 31.6% (95% CI 28.8%
to 34.4%) had raised BP; metabolic syndrome was
present in 16.5% (95% CI 13.5% to 19.5%).
DISCUSSION
Health professionals depend on estimates of the fre-
quency of metabolic syndrome to plan effective strat-
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Table 3 Weighted prevalence of metabolic syndrome and its components by sex and age group among Qataris
% (95% CI)
N exposed/
N available All age groups 18–29 years 30–39 years 40–49 years 50–59 years 60–64 years
Both sexes (n=2496)
Metabolic syndrome (≥3 risk factors)* 430/1373 27.7% (24.5% to 30.9%) 9.3% (6.0% to 12.7%) 26.0% (19.8% to 32.3%) 37.9% (32.2% to 43.6%) 54.0% (45.2% to 62.7%) 70.2% (54.1% to 86.3%)
Raised fasting blood glucose† 374/1470 22.5% (19.0% to 26.0%) 12.3% (7.9% to 16.8%) 15.7% (9.6% to 21.9%) 31.0% (24.7% to 37.4%) 44.7% (35.8% to 53.7%) 55.0% (40.3% to 69.7%)
Raised BP‡ 1107/2432 42.7% (40.0% to 45.4%) 28.2% (23.7% to 32.6%) 36.2% (31.6% to 40.9%) 54.9% (50.2% to 59.6%) 73.9% (68.0% to 79.8%) 87.5% (78.4% to 96.7%)
Raised triglycerides§ 270/1518 16.4% (13.7% to 19.0%) 9.0% (5.7% to 12.3%) 18.1% (12.7% to 23.5%) 20.6% (15.9% to 25.2%) 26.5% (18.0% to 35.0%) 24.2% (12.7% to 35.8%)
Reduced HDL cholesterol¶ 676/1526 45.5% (41.3% to 49.8%) 38.4% (31.7% to 45.1%) 48.1% (40.8% to 55.3%) 49.1% (42.4% to 55.7%) 51.7% (43.7% to 59.7%) 62.3% (47.6% to 77.0%)
Abdominal obesity** 1302/2356 50.6% (47.7% to 53.6%) 33.0% (28.1% to 37.9%) 54.2% (49.0% to 59.5%) 64.4% (59.7% to 69.2%) 68.9% (62.7% to 75.1%) 75.6% (64.0% to 87.3%)
Men (n=1053)
Metabolic syndrome (≥3 risk factors)* 179/538 28.7% (23.6% to 33.7%) 9.5% (4.4% to 14.6%) 26.4% (17.8% to 34.9%) 38.5% (30.2% to 46.9%) 62.3% (50.0% to 74.5%) 66.6% (42.0% to 91.2%)
Raised fasting blood glucose† 152/552 23.1% (17.6% to 28.6%) 11.4% (6.0% to 16.9%) 13.6% (5.2% to 21.9%) 34.6% (24.3% to 44.9%) 50.8% (36.7% to 64.9%) 55.5% (32.3% to 78.6%)
Raised BP‡ 470/1022 42.1% (38.5% to 45.6%) 25.8% (20.0% to 31.7%) 35.1% (28.3% to 41.9%) 54.5% (47.5% to 61.5%) 80.1% (73.2% to 86.9%) 86.9% (74.8% to 99.0%)
Raised triglycerides§ 110/573 17.2% (13.0% to 21.3%) 6.5% (1.5% to 11.4%) 21.2% (12.7% to 29.7%) 20.4% (13.6% to 27.3%) 33.3% (19.2% to 47.3%) 25.4% (9.4% to 41.5%)
Reduced HDL cholesterol¶ 290/575 51.9% (45.2% to 58.6%) 45.8% (34.9% to 56.7%) 53.8% (41.1% to 66.5%) 54.6% (45.8% to 63.5%) 56.7% (45.9% to 67.4%) 65.0% (43.6% to 86.3%)
Abdominal obesity** 541/1031 50.7% (46.0% to 55.5%) 38.6% (31.2% to 46.0%) 54.9% (46.7% to 63.1%) 58.7% (50.9% to 66.5%) 64.2% (55.1% to 73.3%) 68.1% (50.1% to 86.0%)
Women (n=1443)
Metabolic syndrome (≥3 risk factors)* 251/835 26.8% (23.1% to 30.4%) 9.1% (4.2% to 14.0%) 25.6% (17.7% to 33.5%) 37.3% (28.6% to 46.0%) 46.7% (37.2% to 56.2%) 75.8% (59.0% to 92.6%)
Raised fasting blood glucose† 222/918 21.9% (17.7% to 26.1%) 13.1% (7.1% to 19.2%) 18.2% (10.6% to 25.8%) 27.9% (20.3% to 35.6%) 39.5% (26.9% to 52.0%) 54.2% (34.5% to 74.0%)
Raised BP‡ 637/1410 43.3% (38.9% to 47.6%) 30.3% (23.5% to 37.2%) 37.4% (30.3% to 44.4%) 55.2% (48.3% to 62.0%) 67.9% (60.5% to 75.3%) 88.3% (79.3% to 97.4%)
Raised triglycerides§ 160/945 15.6% (12.6% to 18.6%) 11.2% (6.2% to 16.2%) 14.6% (8.8% to 20.4%) 20.7% (14.8% to 26.5%) 20.8% (13.2% to 28.3%) 22.3% (6.3% to 38.2%)
Reduced HDL cholesterol¶ 386/951 39.4% (34.6% to 44.2%) 31.7% (24.4% to 39.0%) 41.5% (33.4% to 49.6%) 44.1% (35.3% to 52.9%) 47.4% (36.9% to 58.0%) 58.0% (37.7% to 78.3%)
Abdominal obesity** 761/1325 50.5% (47.1% to 53.9%) 26.9% (20.9% to 33.0%) 53.5% (46.9% to 60.0%) 69.2% (63.6% to 74.8%) 73.6% (65.5% to 81.6%) 85.1% (73.7% to 96.5%)
*Metabolic syndrome status could only be determined for 1373 participants (538 men, 835 women) having complete data for the five components.
†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).
‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).
§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).
¶Reduced HDL cholesterol (<40 mg/dL in men; <50 mg/dL in women or specific treatment for this lipid abnormality).
**Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m2).
































given population. Thus, it is extremely important that
the estimated prevalence of metabolic syndrome be reli-
able and based on information that is appropriate for
the selected region or country.
The major organisations concerned with defining
metabolic syndrome recognise that central adiposity—an
important component of this syndrome—is most easily
measured by waist circumference.1 2 Furthermore, the
IDF has emphasised the need for determining country-
specific estimates of cut-off points for waist circum-
ference in calculating the prevalence of metabolic
syndrome. In fact, there is good evidence that body com-
position varies among ethnic groups, Asians having
lower cut-off points than Europeans, and African-
Americans and Hispanics having similar cut-off points to
Europeans. Differences between populations could relate
to genetic differences that may affect body composition,
environmental exposure and particularly nutritional dif-
ferences such as early childhood nutrition exposures.8 A
number of region-specific or population-specific estimates
have been published, but there are only a few for Middle
East countries and none for Qatar (table 6).
In previous publications, Bener et al3 9 suggested that
previous criteria for estimating the risk of metabolic syn-
drome as recommended by the WHO, the IDF and
ATP-III might be inappropriate for Qatar. In particular,
he and his coauthors proposed BMI, waist-to-hip and
waist-to-height ratio in alternative to waist circumference
as a measure of central obesity.3 We used data from the
2012 Qatar National STEPwise Survey to calculate the
current prevalence of metabolic syndrome in Qatar. We
confirmed that waist circumference was an appropriate
parameter for identifying other individual components
of metabolic syndrome. For the entire Qatari adult
Table 4 Characteristics associated with metabolic syndrome at multivariable analysis
Characteristics* Total
Percentage of participants
with metabolic syndrome OR (95% CI)†
All 1373 27.7
Gender
Men 538 28.7 1.00
Women 835 26.8 0.83 (0.62 to 1.12)
Age group (years)
18–29 337 9.3 1.00
30–39 353 26.0 3.40 (2.02 to 5.74)
40–49 396 37.9 5.66 (3.65 to 8.78)
50–59 214 54.0 10.25 (5.98 to 17.6)
60–64 73 70.2 18.24 (7.01 to 47.5)
Education
Less than primary school 169 50.0 1.00
Primary/preparatory school 312 30.3 0.70 (0.39 to 1.26)
Secondary school or more 891 23.3 0.61 (0.39 to 0.96)
Marital status
Never married 263 10.3 1.00
Currently married 979 33.2 1.40 (0.67 to 2.94)
Divorced 81 41.8 1.97 (0.87 to 4.43)
Widowed 50 52.5 1.73 (0.51 to 5.90)
Occupation
Government employee 631 24.2 1.00
Non-government employee 64 23.7 1.07 (0.40 to 2.83)
Student 117 4.3 0.38 (0.14 to 1.06)
Homemaker 354 37.6 1.56 (0.94 to 2.59)
Retired 157 53.6 1.53 (0.94 to 2.49)
Tobacco smoking‡
Never smoked tobacco 1126 28.1 1.00
Ever smoked tobacco 247 26.5 0.76 (0.47 to 1.23)
Currently smoke tobacco 195 23.7 0.72 (0.47 to 1.12)
Currently smoke daily tobacco 177 23.4 0.71 (0.45 to 1.12)
Physical activity
Low (<600 MET-min/week) 643 31.9 1.00
Average (600–3000 MET-min/week) 304 29.3 0.90 (0.64 to 1.28)
High (≥3000 MET-min/week) 398 20.4 0.60 (0.42 to 0.86)
Information on education was not available for 1 participant, occupation for 50 participants and physical activity for 28 participants.
*Results are not presented when based on responses from <30 participants.
†ORs and 95% CIs obtained from multivariable logistic regression model adjusted for age, sex and education level.
‡Any form of tobacco including cigarettes, cigars, pipe, Shisha or Medwakh.
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Table 5 Weighted prevalence of metabolic syndrome and its components by sex and age group among 1785 Qataris who reported not having been told by a doctor or other health worker that they had
raised BP (or hypertension) or raised blood sugar (or diabetes)
% (95% CI)
N exposed/
N available All age groups 18–29 years 30–39 years 40–49 years 50–59 years
Both sexes (n=1785)
Metabolic syndrome (≥3 risk factors)* 177/963 16.5% (13.5% to 19.5%) 5.5% (2.6% to 8.4%) 22.0% (15.5% to 28.4%) 25.9% (19.5% to 32.3%) 31.3% (19.1% to 43.4%)
Raised fasting blood glucose† 151/1042 13.7% (10.1% to 17.2%) 9.8% (5.4% to 14.3%) 13.6% (7.3% to 19.8%) 19.5% (13.7% to 25.3%) 20.8% (11.6% to 30.0%)
Raised BP‡ 568/1733 31.6% (28.8% to 34.4%) 24.0% (19.9% to 28.1%) 31.5% (26.2% to 36.8%) 45.0% (39.2% to 50.8%) 48.2% (37.7% to 58.7%)
Raised triglycerides§ 147/1077 12.4% (9.9% to 14.8%) 7.9% (4.6% to 11.2%) 15.6% (10.5% to 20.7%) 15.3% (10.4% to 20.3%) 19.8% (8.3% to 31.3%)
Reduced HDL cholesterol¶ 441/1083 42.9% (38.1% to 47.8%) 38.3% (30.9% to 45.8%) 46.5% (38.5% to 54.5%) 47.9% (39.4% to 56.4%) 40.5% (29.1% to 51.9%)
Abdominal obesity** 783/1666 43.8% (40.2% to 47.4%) 31.2% (25.8% to 36.6%) 51.2% (44.8% to 57.6%) 57.1% (51.1% to 63.1%) 61.4% (52.2% to 70.6%)
Men (n=765)
Metabolic syndrome (≥3 risk factors)* 81/390 17.6% (13.1% to 22.1%) 5.0% (1.1% to 8.8%) 24.1% (15.1% to 33.0%) 28.3% (19.0% to 37.6%) 34.3% (16.1% to 52.5%)
Raised fasting blood glucose† 59/399 13.0% (7.9% to 18.1%) 7.4% (2.9% to 11.8%) 12.4% (3.7% to 21.1%) 22.9% (12.9% to 32.9%) 25.1% (9.3% to 40.9%)
Raised BP‡ 243/741 30.3% (26.4% to 34.2%) 21.4% (15.4% to 27.4%) 30.7% (23.2% to 38.2%) 44.5% (36.1% to 52.9%) 51.5% (37.7% to 65.3%)
Raised triglycerides§ 62/415 13.4% (9.2% to 17.7%) 6.3% (1.0% to 11.6%) 18.2% (9.7% to 26.7%) 18.7% (11.4% to 26.0%) 25.6% (5.5% to 45.7%)
Reduced HDL cholesterol¶ 195/416 49.3% (41.1% to 57.4%) 44.7% (33.0% to 56.4%) 52.6% (39.1% to 66.1%) 53.0% (41.8% to 64.2%) 47.8% (28.5% to 67.1%)
Abdominal obesity** 351/750 46.1% (40.6% to 51.6%) 38.2% (30.4% to 46.0%) 52.2% (43.3% to 61.2%) 53.9% (44.2% to 63.7%) 50.9% (36.4% to 65.3%)
Women (n=1020)
Metabolic syndrome (≥3 risk factors)* 96/573 15.3% (11.8% to 18.8%) 6.0% (2.1% to 10.0%) 19.0% (11.3% to 26.7%) 23.5% (14.8% to 32.3%) 29.2% (15.1% to 43.3%)
Raised fasting blood glucose† 92/643 14.3% (10.0% to 18.6%) 12.0% (5.5% to 18.5%) 15.1% (8.1% to 22.0%) 16.2% (9.6% to 22.8%) 17.9% (5.9% to 29.9%)
Raised BP‡ 325/992 32.9% (28.5% to 37.3%) 26.5% (20.2% to 32.7%) 32.4% (25.4% to 39.4%) 45.4% (37.6% to 53.3%) 45.8% (32.7% to 59.0%)
Raised triglycerides§ 85/662 11.3% (8.2% to 14.3%) 9.4% (4.7% to 14.1%) 12.4% (7.4% to 17.4%) 12.1% (6.6% to 17.7%) 15.5% (4.2% to 26.8%)
Reduced HDL cholesterol¶ 246/667 36.4% (30.9% to 41.9%) 32.5% (24.4% to 40.5%) 38.9% (30.1% to 47.6%) 43.0% (32.2% to 53.9%) 35.0% (20.9% to 49.2%)
Abdominal obesity** 432/916 41.3% (37.6% to 45.1%) 23.4% (17.1% to 29.7%) 49.8% (43.0% to 56.6%) 60.0% (52.6% to 67.3%) 69.0% (56.2% to 82.0%)
Results for those aged 60–64 years are not presented because they are based on responses from <30 participants.
*Metabolic syndrome status could only be determined for 963 participants (390 men, 573 women) having complete data for the five components.
†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).
‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).
§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).
¶Reduced HDL cholesterol (<40 mg/dL in men; <50 mg/dL in women or specific treatment for this lipid abnormality).
**Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m2).
































population, using the best cut-off points for waist cir-
cumference, we estimate the prevalence of metabolic
syndrome in adults to be 28%. This value resembles the
previous overall estimate of 26% for this country
obtained using the ATP-III criteria but considerably
lower than the estimate of 37% derived from using the
IDF criteria.9 For comparison, estimates of the
age-standardised prevalence of metabolic syndrome in
the USA are 23%.10
In a multivariable analysis, the risk of metabolic syn-
drome increased steadily with age: participants aged 60–
64 were 18 times more likely to suffer from metabolic
syndrome than those who were in the 18–30 age group.
The frequency of metabolic syndrome was 39% lower
among participants with the highest level of educational
attainment than in the group with the least amount of
education. Exercise of at least 3000 MET-min/week
lowered the risk of metabolic syndrome by 40% com-
pared with persons in the lowest exercise group. Neither
diet nor smoking had any impact on the occurrence of
metabolic syndrome in this survey. This could be due to
the fact that only basic information was collected on diet
and because smoking prevalence is relatively low in
Qatar. This analysis, however, suggests that among the
various lifestyle factors that might alter the prevalence of
metabolic syndrome in Qatar, exercise is the most
important and deserves emphasis in any disease preven-
tion programme.
Of interest, about 70% of participants in the sample
survey were unaware of pre-existing diabetes or hyper-
tension. After evaluation, 16.5% in this group were even-
tually diagnosed with metabolic syndrome.
The availability of specific waist circumference cut-off
points for Qataris will also allow a better identification of
the metabolic syndrome at the individual level in this
population. Using lower cut-off points for Europeans,
which are recommended in the absence of ethnicity spe-
cific data, would markedly increase the number of indi-
viduals classified at risk of Mets.
The strength of this study is that the data came from a
carefully selected random population sample and data
collection followed well-defined WHO criteria. As in
other surveys, there was a different response rate for each
step, especially for the collection of biological material.
Fifty-five per cent of participants in the Qatar National
STEPwise Survey provided a blood sample, which is still a
fair response rate. Many individuals who live in this
region refuse to provide blood samples for a variety of
cultural reasons in survey situations such as this one, but
we have no reason to believe that the blood sugar values
of study participants who provided blood samples are dif-
ferent from the values of those who did not. However,
this might introduce an unknown bias into the estimate
of the prevalence of metabolic syndrome. We also recog-
nised that treating missing data as a category in the
regression models, as any other method to handle
missing data, such as dropping subjects or imputation,
could again have introduced some bias.
Another study limitation pertains to the accuracy of
self-reported dietary information. This information is an
estimate, which may not be a true measure of past or
present food consumption. This could lead to inappro-
priate conclusions that the diet has no significant impact
on prevention of metabolic syndrome. Finally, as for any
population survey, the assumption was made that the
sample of individuals interviewed is representative of the
whole population. Our careful sampling framework
should guarantee this assumption.
In summary, using new ethnic-specific cut-off points
(≥102 for men and ≥94 cm for women) derived from
the ROC curve analysis of abdominal waist circumfer-
ence, the prevalence of metabolic syndrome in adult
Qataris is 28%. We believe the new cut-off points for
waist measurement from this country could be suitable
for estimating the prevalence of metabolic syndrome in
similar populations from other Middle East countries
where country-specific data for waist measurements are
unavailable.
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Table 6 Ethnic specific values for waist circumference






population Men Women Reference
Iran 89 91 Delavari et al11
Iran 94.5 94.5 Hadaegh et al12
Iran 92.6 97.8 Talaei et al13
Iran 92 95 Mirmiran et al14
Iran 94.5 – Gharipour et al15
Iran 91.5 85.5 Esteghamati et al16
Iran, Kerman 89 86 Gozashti et al17
Iraq 97 99 Mansour et al18
Jordan 97.8 95.6 Al-Odat et al19
Omani Arabs 80 84.5 Al-Lawati et al20
Omani Arabs 78.5 84.5 Al-Lawati et al21
Egypt 93.5 91.5 Ibrahim et al22
Qatar 102 94 Current study
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